Media Centre

 

 

In our media centre you can keep up-to-date with our latest press releases, search through our news archive, send us a media enquiry or view our database of images and videos.

 

If you have any questions please contact either:

 

Julia Winder

PR Manager

Tel: +44 (0)7737 864878

Email: Julia.Winder@surginno.co.uk

 

Fliss Newman

Marketing Manager

Tel: +44 (0)7720 975707

Email: Fliss.Newman@surginno.co.uk

 

SI IMAGES
Browse image library
 
SI FILM LIBRARY
SI's latest films
 
RNS
Browse RNS feeds



Latest news from Surgical Innovations


Wednesday, 17 December, 2014

 

Surgical Innovations Group plc (AIM: SUN) announces that, following the exercise of options by a Director today, it has issued and allotted 400,000 ordinary shares of 1p each.

...


...........................................................................................................................................................................................

Tuesday, 18 November, 2014

 

...


...........................................................................................................................................................................................

Thursday, 6 November, 2014

The Board of Surgical Innovations announces that on 5 November 2014, Mike Thornton served notice of his intention to resign as Chief Financial Officer of the Company.  Mr Thornton will continue to carry out his existing duties during his nine month notice period, which can be terminated earlier by mutual agreement. 

 

 

Doug Liversidge, Chairman, said: “I would like to thank Mike, on behalf of the Board, for his...


...........................................................................................................................................................................................

Wednesday, 22 October, 2014

 

Since the release of Surgical Innovations’ interim results on 25 September 2014, the Board has conducted a further review of the Company’s balance sheet. 

 

The Board’s review, which has now been concluded, will result in exceptional charges of approximately £1.6 million being incurred, which will be recognised in the Company’s results for the year to 31 December 2014. These are in addition to the exceptional charges incurred in the Company’s recent...


...........................................................................................................................................................................................